StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Board MeetingMay 4, 2026, 08:16 AM

Evaxion to Announce Q1 2026 Results & Business Update May 7

AI Summary

Evaxion A/S, a clinical-stage TechBio company, announced it will provide a business update and report its first quarter 2026 financial results on Thursday, May 7, 2026, before the Nasdaq CM opens. The company's Executive Management will host a conference call and webcast on the same day at 14:30 CET/08:30 EST to present the update and results, and to answer questions. Registration is required for the conference call, and a webcast recording will be available online.

Key Highlights

  • Evaxion will announce its first quarter 2026 financial results and provide a business update on May 7, 2026.
  • The announcement will be made before the opening of the Nasdaq CM.
  • Executive Management will host a conference call and webcast on May 7, 2026, at 14:30 CET/08:30 EST.
  • Participants must register in advance for the conference call to receive dial-in details and a unique PIN code.
  • A webcast recording will be available on Evaxion's website shortly after the event.